ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $865 | -9.5% | 31,886 | +2.5% | 0.03% | -3.6% |
| Q2 2023 | $956 | -6.3% | 31,101 | +9.9% | 0.03% | -12.5% |
| Q1 2023 | $1,020 | -4.7% | 28,307 | +4.6% | 0.03% | -13.5% |
| Q4 2022 | $1,070 | -99.9% | 27,072 | +3.5% | 0.04% | -7.5% |
| Q3 2022 | $1,051,000 | -8.4% | 26,157 | -4.2% | 0.04% | +2.6% |
| Q2 2022 | $1,148,000 | +9.0% | 27,302 | +1.0% | 0.04% | +30.0% |
| Q1 2022 | $1,053,000 | +2.9% | 27,024 | +5.3% | 0.03% | +7.1% |
| Q4 2021 | $1,023,000 | +128.3% | 25,669 | +107.0% | 0.03% | +100.0% |
| Q3 2021 | $448,000 | -11.8% | 12,398 | 0.0% | 0.01% | -17.6% |
| Q2 2021 | $508,000 | -9.0% | 12,398 | -3.0% | 0.02% | -10.5% |
| Q1 2021 | $558,000 | – | 12,786 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |